Statin therapy blunts inflammatory activation and improves prognosis and left ventricular performance assessed by Tissue Doppler Imaging in subjects with chronic ischemic heart failure: results from the Daunia Heart Failure Registry
Authors:
- Michele CorrealeMichele Correale
- Natale Daniele BrunettiNBNatale Daniele Brunetti
- Antonio TotaroATAntonio Totaro
- Deodata MontroneDMDeodata Montrone
- Anna Rita RussoARAnna Rita Russo
- Anna Maria FanigliuloAFAnna Maria Fanigliulo
- Riccardo IevaRIRiccardo Ieva
- Matteo Di BiaseMBMatteo Di Biase
Open Access
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Do Statins Improve Heart Failure Outcome in Post–Myocardial Infarction Patients With Moderate to Severe Left Ventricular Dysfunction?Congestive Heart Failure, 2010
- Effects of Statin Therapy According to Plasma High-Sensitivity C-Reactive Protein Concentration in the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA)Circulation, 2009
- Atorvastatin Improves Endothelial Function and Cardiac Performance in Patients with Dilated Cardiomyopathy: The Role of InflammationCardiovascular Drugs and Therapy, 2009
- Inflammatory Mediators in Chinese Patients With Congestive Heart FailureThe Journal of Clinical Pharmacology, 2009
- Relation of Statin Therapy to Risk of Heart Failure After Acute Myocardial InfarctionThe American Journal of Cardiology, 2008
- Assessment of Regional Systolic and Diastolic Functions Affected by Atorvastatin in Coronary Artery Disease Using Tissue Doppler ImagingClinical Cardiology, 2008
- Atorvastatin and statins in the treatment of heart failureExpert Opinion on Pharmacotherapy, 2007
- Statin use was associated with reduced mortality in both ischemic and nonischemic cardiomyopathy and in patients with implantable defibrillators: Mortality data and mechanistic insights from the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT)American Heart Journal, 2007
- The effects of initiation or continuation of statin therapy on cholesterol level and all-cause mortality after the diagnosis of left ventricular systolic dysfunctionAmerican Heart Journal, 2007
- Effects of the 3-hydroxy-3-methylglutaryl-CoA reductase inhibitors, atorvastatin and simvastatin, on the expression of endothelin-1 and endothelial nitric oxide synthase in vascular endothelial cells.Journal of Clinical Investigation, 1998